- Investing Ideas
- Belgian Pharmaceuticals & Biotech Price disconnect
Belgian Pharmaceuticals & Biotech Price disconnect
Results
2
0 new
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
2 companies
argenx
Market Cap: €50.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€748.60
7D
-4.1%
1Y
55.0%
UCB
Market Cap: €47.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€255.00
7D
1.0%
1Y
51.0%